Highly-stabilized and selective inhibitor for cancer-causing enzyme developed

A team of researchers from the Hebrew University of Jerusalem, the Weizmann Institute of Science, and the University of Tokyo has made a significant breakthrough in the fight against cancer by developing a highly selective inhibitor for an enzyme called Matrix Metallopeptidase 7 (MMP7). This enzyme plays a crucial role in cancer progression, especially in helping tumors invade surrounding tissues and spread to other parts of the body (metastasis). The findings are published in the journal Angewandte Chemie International Edition.